nach oben

Current Allergy and Asthma Reports

Erschienen in:

01.12.2012 | OTITIS (DP SKONER, SECTION EDITOR)

Cytokine Responses in the Common Cold and Otitis Media

verfasst von: Todd M. Wine, Cuneyt M. Alper

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Cytokines are a group of diverse molecules that influence the function of every organ system. They are most well studied in their effects on the immune system and their integral role in mediating inflammation. The common cold and otitis media are two such disease states, and much has been learned about the various effects of cytokines in each disease. Most often the viruses isolated include rhinovirus (RV), respiratory syncytial virus (RSV), adenovirus, coronavirus, and picornavirus. Otitis media, sinusitis, bronchiolitis, pneumonia, and asthma exacerbation are commonly accepted as complications of viral upper respiratory tract infections. Furthermore, otitis media and upper respiratory infections are inextricably linked in that the majority (>70 %) of cases of acute otitis media occur as complications of the common cold. Cytokine polymorphisms have been associated with the severity of colds as well as the frequency of otitis media. This article attempts to update the reader on various studies that have recently been published regarding the role of cytokines in these two disease entities.

Alper CM, Doyle WJ, Winther B, Hendley JO. Upper respiratory virus detection without parent-reported illness in children is virus-specific. J Clin Virology. 2008;42:120–2.CrossRef

Makela MJ, Puhakka T, Ruuskanen O, et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 1998;36(2):539.PubMed

Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalence of bacteria and virus. Clin Infect Dis. 2006;43:1417–22.PubMedCrossRef

Song J, Jin Y, Xie Z, et al. Novel human bocavirus in children with acute respiratory tract infection. Emerg Infect Dis. 2010;16:324–7.PubMedCrossRef

Suzuki A, Watanabe O, Okamoto M et al. Detection of human metapneumovirus from children with acute otitis media. Pediatr Infect Dis;2005:655–57.

Winther B, Alper CM, Mandel EM, et al. Temporal relationships between colds, upper respiratory viruses detected by polymerase chain reaction, and otitis media in young children followed through a typical cold season. Pediatrics. 2007;119:1069–75.PubMedCrossRef

Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487–94.PubMedCrossRef

Klein JO. The burden of otitis media. Vaccine. 2000;19 Supp 1:S2–8.PubMedCrossRef

Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001;33:757–62.PubMedCrossRef

10.

Noah TL, Henderson FW, Wortman IA, et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis. 1995;171(3):584–92.PubMedCrossRef

11.

Röseler S, Holtappels G, Wagenmann M, Bachert C. Elevated levels of interleukins IL-1 beta, IL-6, and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol. 1995;252 suppl 1:S61–3.PubMedCrossRef

12.

Laham FR, Israele V, Casellas JM, et al. Differential production of inflammatory cytokines in primary infection with human metapneumonvirus and with other common respiratory viruses of infancy. J Infect Dis. 2004;189(11):2047–56.PubMedCrossRef

13.

Kaiser L, Fritz RS, Straus SE, et al. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol. 2001;64(3):262–8.PubMedCrossRef

14.

Noah TL, Ivins SS, Murphy P, et al. Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis. Clin Immunol. 2002;104(1):86–95.PubMedCrossRef

15.

Oh JW, Lee HB, Park IK, Kang JO. Interleukin-6, interleukin-8, interleukin-11, and interferon-gamma levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection. Pediatr Allergy Immunol. 2002;13(5):350–6.PubMedCrossRef

16.

Garofalo RP, Hintz KH, Hill V, et al. Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J Med Virol. 2004;73(2):289–94.PubMedCrossRef

17.

Revai K, Petal JA, Grady JJ, et al. Association between cytokine gene polymorphisms and risk for upper respiratory tract infection and acute otitis media. Clin Infect Dis. 2009;49(2):257–61.PubMedCrossRef

18.

Gentile DA, Doyle WJ, Zeevi A, Howe-Adams J, Kapadia S, Trecki J, et al. Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. Hum Immunol. 2003;64(3):338–44.PubMedCrossRef

19.

• Broers CJ, Gemke RJBJ, Wigerman ME, et al. Increased pro-inflammatory cytokine production in Down syndrome children upon stimulation with live influenza A virus. J Clin Immunol. 2012;32:323–9. This study showed that cytokine responses were altered in viral infection in a Down syndrome cohort. This idea merits further study in the effect of cytokine response in the common cold and otitis media.PubMedCrossRef

20.

Cohen S, Janicki-Deverts D, Mller G. Psychological stress and disease. JAMA. 2007;298(14):1685–7.PubMedCrossRef

21.

•• Cohen S, Janicki-Deverts D, Doyle WJ, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. PNAS. 2012;109(16):5995–9. Via the glucocorticoid receptor, this study was able to show that chronic stress can modulate the immune system leading to increased susceptibility to cold. The true importance may be creating molecular theory diagraming how chronic stress plays an important role in myriad diseases.PubMedCrossRef

22.

• Pinto R, Herold S, Cakarova L, Hoegner K, Lohmeyer J, Planz O, et al. Inhibition of influenza virus-induced NF-kappaB and raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo. Antiviral Res. 2011;92(1):45–56. This is the first study to identify molecular mechanisms by which both viral replication and cytokine production can be simultaneously reduced suggesting a potential therapeutic target.PubMedCrossRef

23.

McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19(3):571–82.PubMedCrossRef

24.

Patel JA, Nguyen DT, Reval K, Chonmaitree T. Role of respiratory syncytial virus in acute otits media: implications for vaccine development. Vaccine. 2007;25:1683–9.PubMedCrossRef

25.

Chonmaitree T, Revai K, Grady JJ, et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis. 2008;46(6):815–23.PubMedCrossRef

26.

Henderson FW, Collier AM, Sanyal MA, et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. NEJM. 1982;306:1377–83.PubMedCrossRef

27.

Bueno SM, Gonzalez PA, Riedel CA, et al. Local cytokine response upon respiratory syncytial virus infection. Immunol Lett. 2011;136(2):122–9.PubMedCrossRef

28.

Patel JA, Nair S, Revai K, Grady J, Chonmaitree T. Nasopharyngeal acute phase cytokines in viral upper respiratory infection: impact on acute otitis media in children. Pediatr Infect Dis J. 2009;28(11):1002–7.PubMedCrossRef

29.

• Heinonen S, Silvennoinen H, Lehtinen P, et al. Early oseltamivir treatment of influenza in children 1–3 years of age: a randomized controlled trial. Clin Infect Dis. 2010;51(8):887–94. This study illustrates the possible benefit of antiviral therapy and reduction of disease severity and risk of developing complications from influenza.PubMedCrossRef

30.

Juhn SK, Jung MK, Hoffman MD, Drew BR, Preciado DA, Sausen NJ, et al. The role of inflammatory mediators in the pathogenesis of otitis media and sequelae. Clin Exp Otorhinolaryngol. 2008;1(3):117–38.PubMedCrossRef

31.

Ophir D, Hahn T, Schattner A, Wallach D, Aviel A. Tumor necrosis factor in middle ear effusions. Arch Otolaryngol Head Nec Surg. 1988;114(11):1256–8.CrossRef

32.

Skotnicka B, Hassmann E. Cytokines in children with otitis media with effusion. Eur Arch Otorhinolaryngol. 2000;257:323–6.PubMedCrossRef

33.

Catanzaro A, Ryan A, Bather S, Wasserman SI. The response to human rIL-1, rIL-2, and rTNF in the middle ear of guinea pigs. Laryngoscope. 1991;101:271–5.PubMedCrossRef

34.

Maxwell K, Leonard G, Kreutzer DL. Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor. Arch Otolaryngol Head Neck Surg. 1997;123:984–8.PubMedCrossRef

35.

Nell MJ, Grote JJ. Endotoxin and tumor necrosis factor-alpha in middle ear effusions in relation to upper airway infection. Laryngoscope. 1999;109:1815–9.PubMedCrossRef

36.

Leichtle A, Henandez M, Ebmeyer J, et al. CC chemokine ligand 3 overcomes the bacteriocidal and phagocytic defect of macrophages and hastens recovery from experimental otitis media in TNF−/− mice. J Immunol. 2010;184:3087–97.PubMedCrossRef

37.

Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296:1634–5.PubMedCrossRef

38.

Mathew SJ, Haubert D, Krönke M, Leptin M. Looking beyond death: a morphogenetic role for the TNF signaling pathway. J Cell Sci. 2009;122:1939–46.PubMedCrossRef

39.

• Ebmeyer J, Leichtle A, Hernandez M, et al. TNFA deletion alters apoptosis as well as caspase 3 and 4 expression during otitis media. BMC Immunol. 2011;12:12. This study helps to identify the importance of TNFA in inflammation and apoptosis in otitis media and its subsequent role in maintenance of cellular architecture.PubMedCrossRef

40.

Connolly DT, Jeuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84:1470–8.PubMedCrossRef

41.

Sun D, Matsune S, Ohori J, et al. TNF-alpha and endotoxin increase hypoxia-induced VEGF production by cultured human nasal fibroblasts in synergistic fashion. Auris Nasus Larynx. 2005;32:243–9.PubMedCrossRef

42.

Kim TH, Chae SW, Kim HJ, Jung HH. Effect of recombinant vascular endothelial growth factor on experimental otitis media with effusion. Acta Otolaryngol. 2005;125:256–9.PubMedCrossRef

43.

• Sekiyama K, Ohori J, Matsune S, Kurono Y. The role of vascular endothelial growth factor in pediatric otitis media with effusion. Auris Nasus Larynx. 2011;38(3):319–24. This study highlights the importance of VEGF in effusions and correlates it to presence of bacteria and mucoid effusions.PubMedCrossRef

44.

Cureoglu S, Schachern P, Rinaldo A, et al. Round window membrane and labyrinthine pathological changes: an overview. Acta Otolaryngol. 2005;125:9–15.PubMedCrossRef

45.

Schachern P, Tsuprun V, Cureoglu S, et al. The round window membrane in otitis media: effect of pneumococcal proteins. Arch Otolaryngol Head Neck Surg. 2008;134:658–62.PubMedCrossRef

46.

Moon S, Woo J-I, Lee H-Y, et al. Toll-like receptor 2-dependent NF-kappaB activation is involved in nontypeable Haemophilus influenza-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear. Infect Immun. 2007;75:3361–72.PubMedCrossRef

47.

•• MacArthur CJ, Pillers DA, Pang J, Kempton JB, Trune DR. Altered expression of middle and inner ear cytokines in mouse otitis media. Laryngoscope. 2011;121(2):365–71. This study identifies some of the inner ear cytokine responses that may be targeted for future therapies aimed at protecting inner ear function during acute and chronic otitis media.PubMedCrossRef

48.

Son EJ, Kim SH, Park HY, et al. Activation of epithelial sodium channel in human idle ear epithelial cells by dexamethasone. Eur J Pharmacol. 2009;602:383–7.PubMedCrossRef

49.

Zhang Q, Liu C, Wang J, et al. Expression pattern of aquaporin 4 and 5 in the middle ear of guinea pigs with secretory otitis media. Act Oto-laryngologica. 2010;130:68–74.CrossRef

50.

Choi JY, Choi Y-S, Kim SJ, et al. Interleukin-1β suppresses epithelial sodium channel β-subunit expression and ENaC-dependent fluid absorption in human middle ear epithelial cells. Eur J Pharmacol. 2007;567:19–25.PubMedCrossRef

51.

•• MacArthur CJ, Hausman F, Kempton JB, Trune DR. Murine middle ear inflammation and ion homeostasis gene expression. Otol Neurotol. 2011;32(3):508–15. This key study shows that cytokines are associated with downregulation of ion homeostasis genes during inflammation, suggesting a causative role in the development of middle ear effusion.PubMedCrossRef

52.

Stol K, Diavatopoulos DA, Graamans K, Engel JA, Melchers WJ, Savelkoul HF, et al. Inflammation in the middle ear of children with recurrent or chronic otitis media is associated with bacterial load. Pediatr Infect Dis J.; 2012, Jun 4.

53.

Lee YW, Chung Y, Juhn SK, Kim Y, Lin J. Activation of the transforming growth factor beta pathway in bacterial otitis media. Ann Otol Rhinol Laryngol. 2011;120(3):204–13.PubMed

54.

Cooter MS, Eisma RJ, Burleson JA, et al. Transforming growth factor-beta expression in otitis media with effusion. Laryngoscope. 1998;108(7):1066–70.PubMedCrossRef

55.

Cho JG, Lee ES, Wo JS, et al. Expressions of cyclooxygenase 1 and 2 in endotoxin-induced otitis media with effusion in the rat. Int J Pediatr Otorhinolaryngol. 2007;71:101–6.PubMedCrossRef

56.

Kariya S, Schacher PA, Cureoglu S, et al. Up-regulation of macrophage migration inhibitory factor induced by endotoxin in experimental otitis media with effusion in mice. Acta Otolaryngol. 2008;128:750–5.PubMedCrossRef

57.

Dattaray P, Pudrith C, Nyc MA, et al. Effect of ciprofloxacin/dexamethasone versus ciprofloxacin/hydrocortisone on lipopolysaccharide-induced experimental otitis media. Otolaryngol Head Neck Surg. 2011;145:288–94.PubMedCrossRef

58.

Song J, Kwon SK, Cho CG, et al. Microarray analysis of microRNA expression in LPS induced inflammation of the human middle ear epithelial cells (HMEECs). Int J Pediatr Otorhinolaryngol. 2011;75:648–51.CrossRef

59.

Pudrith C, Martin D, Kim YH, et al. Glucocorticoids reduce nitric oxide concentration in middle ear effusion from lipopolysaccharide induced otitis media. Int J Pediatr Otorhinolaryngol. 2010;74:384–6.PubMedCrossRef

60.

• Eguchi M, Kariya S, Okano M, Higaki T, Makihara S, Fujiwara T, et al. Lipopolysaccharide induces proinflammatory cytokines and chemokines in experimental otitis media through the prostaglandin D2 receptor (DP)-dependent pathway. Clin Exp Immunol. 2011;163(2):260–9. This study reveals a cellular mechanism through which bacterial products cause cytokine production. This suggests that blockade of this receptor may allow reduction in disease severity.PubMedCrossRef

61.

Schreiber S, Garten D, Sudhoff H. Pathophysiological mechanisms of extraesophageal reflux in otolaryngeal disorders. Eur Arch Otorhinolaryngol. 2009;266:17–24.PubMedCrossRef

62.

Tasker A, Dettmar PW, Panetti M, et al. Is gastric reflux a cause of otitis media with effusion in children? Laryngoscope. 2002;112:1930–4.PubMedCrossRef

63.

Abd El-Fattah AM, Abdul Maksoud GA, Ramadan AS, et al. Pepsin assay: a marker for reflux in pediatric glue ear. Otolaryngol Head Neck Surg. 2007;136:464–70.PubMedCrossRef

64.

Başoğlu MS, Eren E, Aslan H, Kolatan HE, Ozbay C, Inan S, et al. Increased expression of VEGF, iNOS, IL-1β, and IL-17 in a rabbit model of gastric content-induced middle ear inflammation. Int J Pediatr Otorhinolaryngol. 2012;76(1):64–9.PubMedCrossRef

65.

Kuczkowski J, Sakowicz-Burkiewicz M, Iżycka-Świeszewska E, Mikaszewski B, Pawełczyk T. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis. ORL J Otorhinolaryngol Relat Spec. 2011;73(2):93–9.PubMedCrossRef

66.

• Sautter NB, Delaney KL, Hausman FA, Trune DR. Tissue remodeling in the acute otitis media mouse model. Int J Pediatr Otorhinolaryngol. 2011;75(11):1368–71. This study highlights the complexity of both inflammatory and tissue remodeling cytokines that occur during otitis media. Understanding the mechanisms of tissue remodeling is important as they may provide potential targets to decrease tissue remodeling seen in otitis media. PubMedCrossRef

67.

Jennings CR, Guo L, Collins HM, Birchall JP. Matrix metalloproteinases 2 and 9 in otitis media with effusion. Clin Otolaryngol. 2001;26:491–4.PubMedCrossRef

68.

Kvaerner KJ, Tambs K, Harris JR, et al. Distribution and heritability of recurrent ear infections. Ann Otol Rhinol Laryngol. 1997;106:624–32.PubMed

69.

Casselbrant ML, Mandel EM, Fall PA, et al. The heritability of otitis media: a twin and triplet study. JAMA. 1999;282:2125–30.PubMedCrossRef

70.

Casselbrant ML, Mandel EM, Rockett HE, et al. The genetic component of middle ear disease in the first 5 years of life. Arch Otolaryngol Head Neck Surg. 2004;130:273–8.PubMedCrossRef

71.

Emonts M, Veenhoven RH, Wiertsema SP, et al. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics. 2007;120:814–23.PubMedCrossRef

72.

Gentile DA, Doyle WJ, Zeevi A, et al. Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. Hum Immunol. 2003;64:338–44.PubMedCrossRef

73.

Alper CM, Winther B, Hendley JO, Doyle WJ. Cytokine polymorphisms predict the frequency of otitis media as a complication of rhinovirus and RSV infection in children. Eur Arch Otorhinolaryngol. 2009;266:199–205.PubMedCrossRef

74.

• McCormick DP, Grady JJ, Diego A, Matalon R, Revai K, Patel JA, et al. Acute otitis media severity: association with cytokine gene polymorphisms and other risk factors. Int J Pediatr Otorhinolaryngol 2011, Mar 25.This is the first study to correlate otitis media severity with environmental and genetic risk factors.

75.

Rye MS, Wiertsema SP, Scaman ES, Oommen J, Sun W, Francis RW, et al. FBXO11, a regulator of the TGFβ pathway, is associated with severe otitis media in western Australian children. Genes Immun. 2011;12(5):352–9.PubMedCrossRef

76.

Tateossian H, Hardisty-Hughes R, Morse S, et al. Regulation of TGFβ signaling by Fbxo11, the gene mutated in the Jeff otitis media mouse mutant. Pathogenetics. 2009;2:5.PubMedCrossRef

77.

Segade F, Daly KA, Alred D, et al. Association of the FBXO11 gene with chronic otitis media with effusion and recurrent otitis media: the Minnesota COME/ROM family study. Arch Otolaryngol Head Neck Surg. 2006;132:729–33.PubMedCrossRef

Titel: Cytokine Responses in the Common Cold and Otitis Media
verfasst von: Todd M. Wine
Cuneyt M. Alper
Publikationsdatum: 01.12.2012
Verlag: Current Science Inc.
Erschienen in: Current Allergy and Asthma Reports / Ausgabe 6/2012
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI: https://doi.org/10.1007/s11882-012-0306-z

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2012

Treatment of Acute Otitis Media in Young Children

Current Knowledge of the Genetics of Otitis Media

An Update on Stem Cell Transplantation in Autoimmune Rheumatologic Disorders

Otitis Media in Infancy and the Development of Asthma and Atopic Disease